How Crohn Disease Medications Work

Crohn's disease is a chronic inflammatory bowel disease characterized by inflammation and ulceration of the gastrointestinal tract. The goal of medication therapy is to induce and maintain remission, reduce symptoms, and improve quality of life.

Gold Standard Treatment: Aminosalicylates (e.g., Sulfasalazine)

• Aminosalicylates work by reducing inflammation in the gastrointestinal tract through their anti-inflammatory properties.
• They inhibit the production of pro-inflammatory mediators, such as leukotrienes and prostaglandins, which contribute to inflammation and tissue damage.

Alternative Treatments: Immunomodulators, Biologics, and JAK Inhibitors

• Immunomodulators (e.g., Azathioprine) suppress the immune system's abnormal response in Crohn's disease, reducing inflammation and preventing tissue damage.
• Biologics (e.g., Infliximab) target specific molecules involved in inflammation, such as tumor necrosis factor-alpha (TNF-α), to reduce inflammation and promote healing.
• JAK inhibitors (e.g., Tofacitinib) block the activity of Janus kinase enzymes, which are involved in signaling pathways that contribute to inflammation and tissue damage.

These medications can be used alone or in combination with aminosalicylates to achieve optimal therapeutic outcomes. The choice of medication depends on disease severity, extent, and patient-specific factors, such as age, comorbidities, and previous treatment responses.